Novel pharmaceutical treatments for minimal traumatic brain injury and evaluation of animal models and methodologies supporting their development

Journal of Neuroscience Methods

Volumn 272, Issue , 2016, Pages 69-76

  Deselms, Hanna ^a   Maggio, Nicola ^a,b   Rubovitch, Vardit ^a   Chapman, Joab ^a,b   Schreiber, Shaul ^a   Tweedie, David ^c   Kim, Dong Seok ^c   Greig, Nigel H ^c   Pick, Chaim G ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Animal models of TBI; Exendin 4; N Acetyl L cycteine; Salubrinal; Thrombin; Traumatic brain injury

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; EXENDIN 4; NEUROPROTECTIVE AGENT; NEUROTROPHIC FACTOR; PROTEINASE ACTIVATED RECEPTOR; SALUBRINAL; THROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FLUID PERCUSSION INJURY; HUMAN; INJURY; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN INJURIES, TRAUMATIC;

ANIMALS; BRAIN INJURIES, TRAUMATIC; HUMANS; MODELS, ANIMAL; NEUROPROTECTIVE AGENTS;

EID: 84959057070     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2016.02.002     Document Type: Article

References (114)

1. Almonte, A.G., Hamill, C.E., Chhatwal, J.P., Wingo, T.S., Barber, J.A., Lyuboslavsky, P.N., et al. Learning and memory deficits in mice lacking protease activated receptor-1. Neurobiol Learn Mem 88 (2007), 295–304.
2. Almonte, A.G., Qadri, L.H., Sultan, F.A., Watson, J.A., Mount, D.J., Rumbaugh, G., et al. Protease-activated receptor-1 modulates hippocampal memory formation and synaptic plasticity. J Neurochem 124 (2013), 109–122.
3. Alvarez, E., Martínez, M.D., Roncero, I., Chowen, J.A., García-Cuartero, B., Gispert, J.D., et al. The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem. J Neurochem 92 (2005), 798–806.
4. Antunes, M., Biala, G., The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process 13 (2012), 93–110.
5. Baratz, R., Tweedie, D., Rubovitch, V., Luo, W., Yoon, J.S., Hoffer, B.J., et al. Tumor necrosis factor-α synthesis inhibitor, 3, 6'-dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice. J Neurochem 118:6 (2011), 1032–1042.
6. Baratz, R., Tweedie, D., Wang, J.Y., Rubovitch, V., Luo, W., Hoffer, B.J., et al. Transiently lowering tumor necrosis factor-α synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in mice. J Neuroinflamm, 12, 2015, 45.
7. Belarbi, K., Jopson, T., Tweedie, D., Arellano, C., Luo, W., Greig, N.H., et al. TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation. J Neuroinflamn, 9, 2012, 23.
8. Bergold, P.J., Treatment of traumatic brain injury with anti-inflammatory drugs. Exp Neurol. 275:Part 3 (2016), 367–380, 10.1016/j.expneurol.2015.05.024.
9. Ben Shimon, M., Lenz, M., Ikenberg, B., Becker, D., Shavit Stein, E., Chapman, J., et al. Thrombin regulation of synaptic transmission and plasticity: implications for health and disease. Front Cell Neurosci, 9, 2015, 151.
10. Bolouri, H., Zetterberg, H., Animal models for concussion: molecular and cognitive assessments—relevance to sport and military concussions. Kobeissy, F.H., (eds.) Brain neurotrauma: molecular, neuropsychological, and rehabilitation aspects, 2015, Boca Raton, FL, CRC Press (Chapter 46).
11. Campbell, J., Drucker, D., Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab 17 (2013), 819–837.
12. Cernak, I., Animal models of head trauma. NeuroRx 2:3 (2005), 410–422.
13. Chen, D., Dorling, A., Critical roles for thrombin in acute and chronic inflammation. J Thromb Haemost 7:Suppl. 1 (2009), 122–126.
14. Cole, J.T., Yarnell, A., Kean, W.S., Gold, E., Lewis, B., Ren, M., et al. Craniotomy: true sham for traumatic brain injury, or a sham of a sham?. J Neurotrauma 28 (2011), 359–369.
15. Coughlin, S.R., Thrombin signalling and protease-activated receptors. Nature 407 (2000), 258–264.
16. Coughlin, S.R., Protease-activated receptors in vascular biology. Thromb Haemost 86 (2001), 298–307.
17. Culmsee, C., Zhu, X., Yu, Q.S., Chan, S.L., Camandola, S., Guo, Z., et al. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. J Neurochem 77 (2001), 220–228.
18. Daneshvar, D.H., Riley, D.O., Nowinski, C.J., McKee, A.C., Stern, R.A., Cantu, R.C., Long-term consequences: effects on normal development profile after concussion. Phys Med Rehabil Clin North Am 22:4 (2011), 683–700.
19. DeWitt, D.S., Perez-Polo, R., Hulsebosch, C.E., Dash, P.K., Robertson, C.S., Challenges in the development of rodent models of mild traumatic brain injury. J Neurotrauma 30:9 (2013), 688–701.
20. Duan, W., Zhu, X., Ladenheim, B., Yu, Q.S., Guo, Z., Oyler, J., et al. p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism. Ann Neurol 52 (2002), 597–606.
21. Duarte, A., Candeias, E., Correia, S.C., Santos, R.X., Carvalho, C., Cardoso, S., et al. Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration. Biochim Biophys Acta 1832 (2013), 527–541.
22. Eakin, K., Baratz-Goldstein, R., Pick, C.G., Zindel, O., Balaban, C.D., Hoffer, M.E., et al. Efficacy of N-acetyl cysteine in traumatic brain injury. PLoS ONE, 9(4), 2014, e90617.
23. Ellis, E.F., Dodson, L.Y., Police, R.J., Restoration of cerebrovascular responsiveness to hyperventilation by the oxygen radical scavenger n-acetylcysteine following experimental traumatic brain injury. J Neurosurg 75 (1991), 774–779.
24. Ennaceur, A., One-trial object recognition in rats and mice: methodological and theoretical issues. Behav Brain Res 215:2 (2010), 244–254.
25. Filichia, F., Shen, H., Zhou, X., Qi, X., Jin, K., Greig, N., et al. Forebrain neuronal specific ablation of p53 gene provide protection in a cortical ischemic stroke model. Neuroscience 295 (2015), 1–10.
26. Foda, M.A., Marmarou, A., A new model of diffuse brain injury in rats. Part II: Morphological characterization. J Neurosurg 80 (1994), 301–313.
27. Frankola, K., Greig, N.H., Luo, W., Tweedie, D., Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases. CNS Neurol Disord Drug Targets 10 (2011), 391–403.
28. Frugier, T., Morganti-Kossmann, M.C., O'Reilly, D., McLean, C.A., In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury. J Neurotrauma 27 (2010), 497–507.
29. Gallwitz, B., Glucagon-like peptide-1 analogues for type 2 diabetes mellitus: current and emerging agents. Drugs 71 (2013), 1675–1688.
30. Gao, X., Chen, J., Mild traumatic brain injury results in extensive neuronal degeneration in the cerebral cortex. J Neuropathol Exp Neurol 70:3 (2011), 183–191.
31. Gingrich, M.B., Junge, C.E., Lyuboslavsky, P., Traynelis, S.F., Potentiation of NMDA receptor function by the serine protease thrombin. J Neurosci 20 (2000), 4582–4595.
32. Gingrich, M.B., Traynelis, S.F., Serine proteases and brain damage—is there a link?. Trends Neurosci 23 (2000), 399–407.
33. Greig, N.H., Giordano, T., Zhu, X., Yu, Q.S., Perry, T.A., Holloway, H.W., et al. Thalidomide-based TNF-alpha inhibitors for neurodegenerative diseases. Acta Neurobiol Exp 64 (2004), 1–9.
34. Greig, N.H., Tweedie, D., Rachmany, L., Li, Y., Rubovitch, V., Schreiber, S., et al. Incretinmimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury. Alzheimers Dement 10:1 (2014), S62–S75.
35. Hall, E.D., High-dose glucocorticoid treatment improves neurological recovery in head-injured mice. J Neurosurg 62 (1985), 882–887.
36. Hicdonmez, T., Kanter, M., Tiryaki, M., Parsak, T., Cobanoglu, S., Neuroprotective effects of N-acetylcysteine on experimental closed head trauma in rats. Neurochem Res 31 (2006), 473–481.
37. Hoffer, M.E., Balaban, C., Slade, M.D., Tsao, J.W., Hoffer, B., Amelioration of acute sequelae of blast induced mild traumatic brain injury by N-acetyl cysteine: a double-blind, placebo controlled study. PLoS ONE, 8(1), 2013, e54163.
38. Hölscher, C., Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases. J Endocrinol 221:1 (2014), T31–T41.
39. Israelsson, C., Wang, Y., Kylberg, A., Pick, C.G., Hoffer, B.J., Ebendal, T., Closed head injury in a mouse model results in molecular changes indicating inflammatory responses. J Neurotrauma 26:8 (2009), 1307–1314.
40. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J.D., et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13 (1999), 76–86.
41. Itzekson, Z., Maggio, N., Milman, A., Shavit, E., Pick, C.G., Chapman, J., Reversal of trauma-induced amnesia in mice by a thrombin receptor antagonist. J Mol Neurosci 53:1 (2014), 87–95.
42. Junge, C.E., Lee, C.J., Hubbard, K.B., Zhang, Z., Olson, J.J., Hepler, J.R., et al. Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes. Exp Neurol 188 (2004), 94–103.
43. Kabadi, S.V., Hilton, G.D., Stoica, B.A., Zapple, D.N., Faden, A.I., Fluid-percussion-induced traumatic brain injury model in rats. Nat Protoc 5 (2010), 1552–1563.
44. Kobayashi, A., Kang, M.I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 24 (2004), 7130–7139.
45. Kappe, C., Tracy, L.M., Patrone, C., Iverfeldt, K., Sjöholm, Å., GLP-1 secretion by microglial cells and decreased CNS expression in obesity. J Neuroinflammation, 9, 2012, 276.
46. Kondo, A., Shahpasand, K., Mannix, R., Qiu, J., Moncaster, J., Chen, C.H., et al. Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy. Nature 523:7561 (2015), 431–436, 10.1038/nature14658.
47. Lee, C.J., Mannaioni, G., Yuan, H., Woo, D.H., Gingrich, M.B., Traynelis, S.F., Astrocytic control of synaptic NMDA receptors. J Physiol 581 (2007), 1057–1081.
48. Leker, R.R., Aharonowiz, M., Greig, N.H., Ovadia, H., The role of p53-induced apoptosis in cerebral ischemia: effects of the p53 inhibitor pifithrin alpha. Exp Neurol 187 (2004), 478–486.
49. Li, Y., Tweedie, D., Mattson, M.P., Holloway, H.W., Greig, N.H., Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells. J Neurochem 113 (2010), 1621–1631.
50. Li, Y., Chigurupati, S., Holloway, H.W., Mughal, M., Tweedie, D., Bruestle, D.A., et al. Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis. PLoS ONE, 7, 2012, e32008.
51. Li, Y., Perry, T., Kindy, M.S., Harvey, B.K., Tweedie, D., Holloway, H.W., et al. GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. PNAS 106 (2009), 1285–1290.
52. Li, Y., Duffy, K.B., Ottinger, M.A., Ray, B., Bailey, J.A., Holloway, H.W., et al. GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease. J Alzheimers Dis 19 (2010), 1205–1219.
53. Li, Y., Bader, M., Tamargo, I., Rubovitch, V., Tweedie, D., Pick, C.G., et al. Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice. J Neurochem. 135:6 (2015), 1203–1217.
54. Lighthall, J.W., Controlled cortical impact: a new experimental brain injury model. J Neurotrauma 5 (1988), 1–15.
55. Lindgren, S., Rinder, L., Experimental studies in head injury. I. Some factors influencing results of model experiments. Biophysik 2 (1965), 320–329.
56. Lippi, G., Favaloro, E.J., Franchini, M., Paradoxical thrombosis, part 2, anticoagulant and antiplatelet therapy. J Thromb Thrombolysis 34 (2012), 367–373.
57. Luo, W., Wang, Y., Reiser, G., Protease-activated receptors in the brain: receptor expression, activation and functions in neurodegeneration and neuroprotection. Brain Res Rev 56 (2007), 331–345.
58. Luo, Y., Kuo, C.C., Shen, H., Chou, J., Greig, N.H., Hoffer, B.J., et al. Delayed treatment with a p53 inhibitor enhances recovery in stroke brain. Ann Neurol 65 (2009), 520–530.
59. Lu, J., Goh, S.J., Tng, P.Y., Deng, Y.Y., Ling, E.A., Moochhala, S., Systemic inflammatory response following acute traumatic brain injury. Front Biosci 14 (2009), 3795–3813.
60. Maggio, N., Itsekson, Z., Dominissini, D., Blatt, I., Amariglio, N., Rechavi, G., et al. Thrombin regulation of synaptic plasticity: implications for physiology and pathology. Exp Neurol 247 (2013), 595–604.
61. Maggio, N., Itsekson, Z., Ikenberg, B., Strehl, A., Vlachos, A., Blatt, I., et al. The anticoagulant activated protein. C. (aPC) promotes metaplasticity in the hippocampus through an EPCR-PAR1-S1P1 receptors dependent mechanism. Hippocampus 24 (2014), 1030–1038.
62. Maggio, N., Shavit, E., Chapman, J., Segal, M., Thrombin induces long-term potentiation of reactivity to afferent stimulation and facilitates epileptic seizures in rat hippocampal slices: toward understanding the functional consequences of cerebrovascular insults. J Neurosci 28 (2008), 732–736.
63. Maggio, N., Shavit-Stein, E., Dori, A., Blatt, I., Chapman, J., Prolonged systemic inflammation persistently modifies synaptic plasticity in the hippocampus: modulation by the stress hormones. Front Mol Neurosci, 6, 2013, 46.
64. Mangels, J.A., Craik, F.I., Levine, B., Schwartz, M.L., Stuss, D.T., Effects of divided attention on episodic memory in chronic traumatic brain injury: a function of severity and strategy. Neuropsychologia 40:13 (2002), 2369–2385.
65. Marmarou, A., Foda, M.A., van den Brink, W., Campbell, J., Kita, H., Demetriadou, K., A new model of diffuse brain injury in rats. Part I: Pathophysiology and biomechanics. J Neurosurg 80 (1994), 291–300.
66. McCoy, M.K., Tansey, M.G., TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation, 5, 2008, 45.
67. Milman, A., Rosenberg, A., Weizman, R., Pick, C.G., Mild traumatic brain injury induces persistent cognitive deficits and behavioral disturbances in mice. J Neurotrauma 22:9 (2005), 1003–1010.
68. Moppett, I., Traumatic brain injury: assessment, resuscitation and early management. Br J Anaesth 99 (2007), 18–31.
69. Morales, D.M., Marklund, N., Lebold, D., Thompson, H.J., Pitkanen, A., Maxwell, W.L., et al. Experimental models of traumatic brain injury: do we really need to build a better mousetrap?. Neuroscience 136:4 (2005), 971–989.
70. Munyon, C., Eakin, K.C., Sweet, J.A., Miller, J.P., Decreased bursting and novel object-specific cell firing in the hippocampus after mild traumatic brain injury. Brain Research 1582 (2014), 220–226.
71. O'Connor, W.T., Smyth, A., Gilchrist, M.D., Animal models of traumatic brain injury: a critical evaluation. Pharmacol Ther 130 (2011), 106–113.
72. Osier, N.D., Korpon, J.R., Dixon, C.E., Controlled cortical impact model. Kobeissy, F.H., (eds.) Brain neurotrauma: molecular, neuropsychological, and rehabilitation aspects, 2015, CRC Press, Boca Raton, FL (2015. Chapter 16).
73. Perry, T., Lahiri, D.K., Chen, D., Zhou, J., Shaw, K.T., Egan, J.M., et al. Induction of differentiation by glucagon-like peptide-1: a novel neurotrophic factor in PC12 cells. J Pharmacol Exp Ther 300 (2002), 958–966.
74. Perry, T., Haughey, N.J., Mattson, M.P., Egan, J.M., Greig, N.H., Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4. J Pharmacol Exp Ther 302 (2002), 881–888.
75. Perry, T., Greig, N.H., The glucagon-like peptides: a double-edged therapeutic sword?. Trends Pharmacol Sci 24 (2003), 377–383.
76. Perry, T., Greig, N.H., Enhancing central nervous system endogenous GLP-1 receptor pathways for intervention in Alzheimer's disease. Curr Alzheimer Res 2 (2005), 377–385.
77. Perry, T., et al. Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy. Exp Neurol 203 (2007), 293–301.
78. Plesnila, N., von Baumgarten, L., Retiounskaia, M., Engel, D., Ardeshiri, A., Zimmermann, R., et al. Delayed neuronal death after brain trauma involves p53-dependent inhibition of NF-kappaB transcriptional activity. Cell Death Differ 14 (2007), 1529–1541.
79. Rachmany, L., Tweedie, D., Rubovitch, V., Yu, Q.S., Li, Y., Wang, J.Y., et al. Cognitive impairments accompanying rodent mild traumatic brain injury involve p53-dependent neuronal cell death and are ameliorated by the tetrahydrobenzothiazole PFT-α. PLoS ONE, 8(11), 2013, e79837.
80. Rachmany, L., Tweedie, D., Li, Y., Rubovitch, V., Holloway, H.W., Miller, J., et al. Exendin-4 induced glucagon-like peptide-1 receptor activation reverses behavioral impairments of mild traumatic brain injury in mice. Age 35:5 (2013), 1621–1636.
81. Reiner, O., Sapir, T., Mark/Par-1 marking the polarity of migrating neurons. Adv Exp Med Biol 800 (2014), 97–111.
82. Rubovitch, V., Barak, S., Rachmany, L., Goldstein, R.B., Zilberstein, Y., Pick, C.G., The neuroprotective effect of salubrinal in a mouse model of traumatic brain injury. Neuromolecular Med 17 (2015), 1–13.
83. Rubovitch, V., Ten-Bosch, M., Zohar, O., Harrison, C.R., Tempel-Brami, C., Stein, E., et al. A mouse model of blast-induced mild traumatic brain injury. Exp Neurol 232:2 (2011), 280–289.
84. 1-42 i.c.v. injection on hippocampal neurogenesis and memory deficit. J Neurochem 122 (2012), 1181–1192.
85. Salcedo, I., Tweedie, D., Li, Y., Greig, N.H., Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders. Br J Pharmacol 166 (2012), 1586–1599.
86. Sambrano, G.R., Weiss, E.J., Zheng, Y.W., Huang, W., Coughlin, S.R., Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature 413 (2001), 74–78.
87. Saso, L., Firuzi, O., Pharmacological applications of antioxidants: lights and shadows. Curr Drug Targets 15 (2014), 1177–1199.
88. Saykally, J.N., Rachmany, L., Hatic, H., Shaer, A., Rubovitch, V., Pick, C.G., et al. The nuclear factor erythroid 2-like 2 activator, tert-butylhydroquinone, improves cognitive performance in mice after mild traumatic brain injury. Neuroscience 223 (2012), 305–314.
89. Shreiber, D.I., Smith, D.H., Meaney, D.F., Immediate in vivo response of the cortex and the blood–brain barrier following dynamic cortical deformation in the rat. Neurosci Lett 259:1 (1999), 5–8.
90. Schreiber, S., Barkai, G., Gur-Hartman, T., Peles, E., Tov, N., Dolberg, O.T., et al. Long-lasting sleep patterns of adult patients with minor traumatic brain injury (mTBI) and non-mTBI subjects. Sleep Med 9 (2008), 481–484.
91. Shohami, E., Gallily, R., Mechoulam, R., Bass, R., Ben-Hur, T., Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-α inhibitor and an effective neuroprotectant. J Neuroimmunol 72 (1997), 169–177.
92. Schuepbach, R.A., Feistritzer, C., Fernández, J.A., Griffin, J.H., Riewald, M., Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1. Thromb Haemost 101 (2009), 724–733.
93. Siller-Matula, J.M., Schwameis, M., Blann, A., Mannhalter, C., Jilma, B., Thrombin as a multi-functional enzyme. Focus on in vitro and in vivo effects. Thromb Haemost 106 (2011), 1020–1033.
94. Spain, A., Daumas, S., Lifshitz, J., Rhodes, J., Andrews, P.J., Horsburgh, K., et al. Mild fluid percussion injury in mice produces evolving selective axonal pathology and cognitive deficits relevant to human brain injury. J Neurotrauma 27:8 (2010), 1429–1438.
95. Spiel, A.O., Bartko, J., Schwameis, M., Firbas, C., Siller-Matula, J., Schuetz, M., et al. Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration. A randomised controlled trial. Thromb Haemost 105 (2011), 655–662.
96. Stiles, T., Kapiloff, M.S., Goldberg, J.L., The role of soluble adenylyl cyclase in neurite outgrowth. Biochim Biophys Acta 1842:12 Pt B (2014), 2561–2568.
97. Tashlykov, V., Katz, Y., Gazit, V., Zohar, O., Schreiber, S., Pick, C.G., Apoptotic changes in the cortex and hippocampus following minimal brain trauma in mice. Brain Res 1130 (2007), 197–205.
98. Tashlykov, V., Katz, Y., Volkov, A., Gazit, V., Schreiber, S., Zohar, O., et al. Minimal traumatic brain injury induce apoptotic cell death in mice. J Mol Neurosci 37 (2009), 16–24.
99. Thompson, H.J., Lifshitz, J., Marklund, N., Grady, M.S., Graham, D.I., Hovda, D.A., et al. Lateral fluid percussion brain injury: a 15-year review and evaluation. J Neurotrauma 22:1 (2005), 42–75.
100. Tuttolomondo, A., Pecoraro, R., Pinto, A., Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date. Drug Des Devel Ther 8 (2014), 2221–2238.
101. Tweedie, D., Milman, A., Holloway, H.W., Li, Y., Harvey, B.K., Shen, H., et al. Apoptotic and behavioral sequelae of mild brain trauma in mice. J Neuroscie Res 85:4 (2007), 805–815.
102. Tweedie, D., Sambamurti, K., Greig, N.H., TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets. Curr Alzheimer Res 4 (2007), 378–385.
103. Tweedie, D., Ferguson, R.A., Fishman, K., Frankola, K.A., Van Praag, H., Holloway, H.W., et al. TNF-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease. J Neuroinflamm, 9, 2012, 106.
104. Tweedie, D., Rachmany, L., Rubovitch, V., Lehrmann, E., Zhang, Y., Becker, K.G., et al. Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice. Exp Neurol 239 (2013), 170–182.
105. Tweedie, D., Rachmany, L., Rubovitch, V., Li, Y., Holloway, H.W., Lehrmann, E., et al. Blast traumatic brain injury-induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4. Alzheimers Dement 12:1 (2016), 34–48.
106. Werner, C., Engelhard, K., Pathophysiology of traumatic brain injury. Br J Anaesth 99:1 (2007), 4–9.
107. Xiong, Y., Peterson, P.L., Lee, C.P., Effect of N-acetylcysteine on mitochondrial function following traumatic brain injury in rats. J Neurotrauma 16 (1999), 1067–1082.
108. Yang, J., You, Z., Kim, H.H., Hwang, S.K., Khuman, J., Guo, S., et al. Genetic analysis of the role of tumor necrosis factor receptors in functional outcome after traumatic brain injury in mice. J Neurotrauma 27 (2010), 1037–1046.
109. Yang, L., Chu, Y.H., Tweedie, D., Yu, Q.S., Pick, C.G., Hoffer, B.J., et al. Post-trauma administration of the pifithrin-α oxygen analogue improves histological and functional outcomes after experimental traumatic brain injury. Exp Neurol 269 (2015), 56–66.
110. Yoon, J.S., Lee, J.H., Tweedie, D., Mughal, M.R., Chigurupati, S., Greig, N.H., et al. 3,6'-dithiothalidomide improves experimental stroke outcome by suppressing neuroinflammation. J Neurosci Res 91 (2013), 671–680.
111. Zhao, Z., Loane, D.J., Murray, M.G., Stoica, B.A., Faden, A.I., Comparing the predictive value of multiple cognitive, affective, and motor tasks after rodent traumatic brain injury. J Neurotrauma 29:15 (2012), 2475–2489.
112. Zhu, X., Yu, Q.S., Cutler, R.G., Culmsee, C.W., Holloway, H.W., Lahiri, D.K., et al. Novel p53 inhibitors with neuroprotective action: syntheses and pharmacological evaluation of 2-imino-2,3,4,5,6,7-hexahydrobenzothiazole and 2-imino-2,3,4,5,6,7-hexahydrobenzoxazole derivatives. J Med Chem 45 (2002), 5090–5097.
113. Zhu, X., Giordano, T., Yu, Q.S., Holloway, H.W., Perry, T., Lahiri, D.K., et al. Thiothalidomides: novel isosteric analogues of thalidomide with enhanced TNF-alpha inhibitory activity. J Med Chem 46 (2003), 5222–5229.
114. Zohar, O., Schreiber, S., Getslev, V., Schwartz, J.P., Mullins, P.G., Pick, C.G., Closed-head minimal traumatic brain injury produces long-term cognitive deficits in mice. Neuroscience 118:4 (2003), 949–955.